| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| XOMA Corp | Chief Executive Officer, Director | Performance Stock Units | 275K | $3.82M | $13.89 | Jan 8, 2024 | Direct |
| XOMA Corp | Chief Executive Officer, Director | Common Stock | 3.5K | $48.6K | $13.89 | Oct 2, 2023 | Direct |
| XOMA Corp | Chief Executive Officer, Director | Depositary Shares - 8.375% B Cumulative Stock | 2K | $47.6K | $23.79 | Oct 2, 2023 | Direct |
| C4 Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 32.5K | Jun 20, 2024 | Direct | ||
| PARDES BIOSCIENCES, INC. | Director | Class A Common Stock | 30K | Dec 23, 2021 | Direct | ||
| Ikena Oncology, Inc. | Director | Stock Option (Right to Buy) | 17.5K | Jun 7, 2024 | Direct | ||
| PARDES BIOSCIENCES, INC. | Director | Class B Common Stock | 0 | Dec 23, 2021 | Direct | ||
| Radius Health, Inc. | Director | Common Stock | 0 | $10.00 | Aug 15, 2022 | Direct | |
| Radius Health, Inc. | Director | Stock Option (Right to Buy) | 0 | $4.16 | Aug 15, 2022 | Direct | |
| Translate Bio, Inc. | Director | Common Stock | 0 | $38.00 | Sep 14, 2021 | Direct | |
| Translate Bio, Inc. | Director | Stock Option (righ to buy) | 0 | Sep 14, 2021 | Direct | ||
| Translate Bio, Inc. | Director | Stock Option (right to buy) | 0 | Sep 14, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CCCC | C4 Therapeutics, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
| IKNA | Ikena Oncology, Inc. | Jun 7, 2024 | 1 | $0 | 4 | Jun 10, 2024 | Director |
| XOMA | XOMA Corp | Jan 8, 2024 | 1 | $0 | 4 | Jan 10, 2024 | Chief Executive Officer, Director |
| CCCC | C4 Therapeutics, Inc. | Nov 16, 2023 | 1 | $0 | 4 | Nov 20, 2023 | Director |
| CCCC | C4 Therapeutics, Inc. | Nov 16, 2023 | 0 | $0 | 3 | Nov 20, 2023 | Director |
| XOMA | XOMA Corp | Oct 2, 2023 | 1 | $13.8K | 4 | Oct 4, 2023 | Exec Chairman and Interim CEO, Director |
| XOMA | XOMA Corp | Sep 25, 2023 | 2 | $36.1K | 4 | Sep 27, 2023 | Exec Chairman and Interim CEO, Director |
| IKNA | Ikena Oncology, Inc. | Jun 9, 2023 | 1 | $0 | 4 | Jun 13, 2023 | Director |
| XOMA | XOMA Corp | May 23, 2023 | 3 | $47.3K | 4 | May 25, 2023 | Interim CEO, Director |
| XOMA | XOMA Corp | Jan 3, 2023 | 2 | $0 | 4 | Jan 5, 2023 | Interim CEO, Director |
| XOMA | XOMA Corp | Jan 1, 2023 | 0 | $0 | 3 | Jan 6, 2023 | Interim CEO, Director |
| IKNA | Ikena Oncology, Inc. | Dec 15, 2022 | 1 | $0 | 4 | Dec 19, 2022 | Director |
| IKNA | Ikena Oncology, Inc. | Dec 14, 2022 | 0 | $0 | 3 | Dec 19, 2022 | Director |
| RDUS | Radius Health, Inc. | Aug 15, 2022 | 3 | -$318K | 4 | Aug 15, 2022 | Director |
| RDUS | Radius Health, Inc. | Jan 14, 2022 | 2 | $0 | 4 | Jan 25, 2022 | Director |
| PRDS | PARDES BIOSCIENCES, INC. | Dec 23, 2021 | 2 | $0 | 4/A | Dec 30, 2021 | Director |
| TBIO | Translate Bio, Inc. | Sep 14, 2021 | 5 | -$1.13M | 4 | Sep 14, 2021 | Director |
| TBIO | Translate Bio, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 16, 2021 | Director |